Multicenter Cross-Sectional Study on Perceptions and Roles of Community Pharmacists in the Prevention and Management of Cardiovascular Disorders in Northwest Ethiopia

References

• Tijburg L, Mattern T, Folts J, Weisgerber U, Katan M. Tea flavonoids and cardiovascular diseases: a review. Crit Rev Food Sci Nutr. 1997;37(8):771–785. doi:10.1080/10408399709527802
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Angaw DA, Ali R, Tadele A, Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord. 2021;21(1):37. doi:10.1186/s12872-020-01828-z
   PubMed Web of Science ®Google Scholar
• Awad A, Al-Nafisi H. Public knowledge of cardiovascular disease and its risk factors in Kuwait: a cross-sectional survey. BMC Public Health. 2014;14(1):1–11. doi:10.1186/1471-2458-14-1131
   PubMed Web of Science ®Google Scholar
• Ali S, Misganaw A, Worku A, et al. The burden of cardiovascular diseases in Ethiopia from 1990 to 2017: evidence from the global burden of disease study. Int Health. 2021;13(4):318–326. doi:10.1093/inthealth/ihaa069
   PubMed Web of Science ®Google Scholar
• Aragaw S, Tesfahun E, Derseh BT, Mamo B. Determinants of selected cardiovascular diseases among adult patients at cardiac clinic of Debre Berhan Referral Hospital, Ethiopia: unmatched case-control study. Cardiovasc Ther. 2020;2020. DOI:10.1155/2020/7036151
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary behavior, exercise, and cardiovascular health. Circ Res. 2019;124(5):799–815. doi:10.1161/CIRCRESAHA.118.312669
   PubMed Web of Science ®Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice< SBT> Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis. 2004;173(2):379–389.
   Web of Science ®Google Scholar
• Omboni S, Caserini M. Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases. Open Heart. 2018;5(1):e000687. doi:10.1136/openhrt-2017-000687
   PubMed Web of Science ®Google Scholar
• George PP, Molina JA, Cheah J, Chan SC, Lim BP. The evolving role of the community pharmacist in chronic disease management-a literature review. Ann Acad Med Singapore. 2010;39(11):861–867.
   PubMed Web of Science ®Google Scholar
• Mossialos E, Courtin E, Naci H, et al. From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(5):628–639. doi:10.1016/j.healthpol.2015.02.007
   PubMed Web of Science ®Google Scholar
• Kii M. Projecting future populations of urban agglomerations around the world and through the 21st century. NPJ Urban Sustain. 2021;1(1):10. doi:10.1038/s42949-020-00007-5
   Google Scholar
• Belachew SA, Muluneh NY, Erku DA, Netere AK. A cross sectional study on beliefs and roles of community pharmacy professionals in preventing and managing metabolic syndrome in an Ethiopian setting. PLoS One. 2020;15(12):e0244211. doi:10.1371/journal.pone.0244211
   PubMed Web of Science ®Google Scholar
• Sia HP, Khan TM, Redzuan AM. Community pharmacists’ perception and experience in providing lifestyle assistance to patients with cardiovascular disease. Int J Pharm Sci & Res. 2020;11(9):4338–48. doi:10.13040/IJPSR.0975-8232.
   Web of Science ®Google Scholar
• Erku DA, Belachew SA, Mekuria AB, et al. The role of community pharmacists in patient counseling and health education: a survey of their knowledge and level of involvement in relation to type 2 diabetes mellitus. Integr Pharm Res Pract. 2017;6:137–143. doi:10.2147/IPRP.S140777
   PubMed Web of Science ®Google Scholar
• Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11(1):582. doi:10.1186/1471-2458-11-582
   PubMed Web of Science ®Google Scholar
• Katoue MG, Awad AI, Kombian SB. Role of community pharmacists in the prevention and management of the metabolic syndrome in Kuwait. Int J Clin Pharm. 2013;35(1):57–64. doi:10.1007/s11096-012-9705-4
   PubMed Web of Science ®Google Scholar
• McKenney JM, Bradberry JC, Talbert RL, Cahill E, Brown WV. National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statin therapy, and pharmacists’ services. J Am Pharm Assoc. 2004;44(5):562–568. doi:10.1331/1544-3191.44.5.562.McKenney
   Google Scholar
• Erku DA, Mersha AG. Involvement of community pharmacists in public health priorities: a multi-center descriptive survey in Ethiopia. PLoS One. 2017;12(7):e0180943. doi:10.1371/journal.pone.0180943
   PubMed Web of Science ®Google Scholar
• Hijazi MA, Shatila H, El-Lakany A, Al Rifai H, Aboul-Ela M, Naja F. Role of community pharmacists in weight management: results of a national study in Lebanon. BMC Health Serv Res. 2020;20(1):386. doi:10.1186/s12913-020-05258-7
   PubMed Web of Science ®Google Scholar
• Fonseca AA, Lima TM. Feasibility of cardiovascular risk screening in Portuguese community pharmacies. Pharm Pract. 2021;19(2):2255. doi:10.18549/PharmPract.2021.2.2255
   PubMed Web of Science ®Google Scholar
• George J, McNamara K, Stewart K. The roles of community pharmacists in cardiovascular disease prevention and management. Australas Med J. 2011;4(5):266–272. doi:10.4066/AMJ.2011.698
   PubMedGoogle Scholar
• Puspitasari HP, Aslani P, Krass I. Australian community pharmacists’ awareness and practice in supporting secondary prevention of cardiovascular disease. Int J Clin Pharm. 2013;35(6):1218–1228. doi:10.1007/s11096-013-9854-0
   PubMed Web of Science ®Google Scholar
• Laliberté M-C, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health. 2012;12(1):1–11. doi:10.1186/1471-2458-12-192
   PubMed Web of Science ®Google Scholar
• El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease‐related health promotion and in hypertension and dyslipidemia management: a cross‐sectional study in the S tate of Q atar. J Eval Clin Pract. 2016;22(3):329–340. doi:10.1111/jep.12477
   PubMed Web of Science ®Google Scholar
• Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14(1):32–38. doi:10.1093/ije/14.1.32
   PubMed Web of Science ®Google Scholar
• Namara KPM, Dunbar JA, Philpot B, Marriott JL, Reddy P, Janus ED. Potential of pharmacists to help reduce the burden of poorly managed cardiovascular risk. Aust J Rural Health. 2012;20(2):67–73. doi:10.1111/j.1440-1584.2012.01259.x
   PubMed Web of Science ®Google Scholar
• Horgan J, Blenkinsopp A, McManus R. Evaluation of a cardiovascular disease opportunistic risk assessment pilot (‘Heart MOT’service) in community pharmacies. J Public Health (Bangkok). 2010;32(1):110–116. doi:10.1093/pubmed/fdp092
   Web of Science ®Google Scholar
• Almansour HA, Aloudah NM, Alhawassi TM, Chaar B, Krass I, Saini B. Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think? J Pharm Policy Pract. 2021;14(1):42. doi:10.1186/s40545-021-00319-6
   PubMedGoogle Scholar